Non-Autoimmune Hemolytic Anemia with Clostridium Ramosum Bacteremia

gan Al-kali, Aref, Oswal, Alok, Tfayli, Arafat
Cyhoeddwyd 2008

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)

gan Al-Kali, Aref, Wierda, William, Keating, Michael, O’Brien, Susan
Cyhoeddwyd 2010

The Role of Monoclonal Antibodies in the Management of Leukemia

gan Al-Ameri, Ali, Cherry, Mohamad, Al-Kali, Aref, Ferrajoli, Alessandra
Cyhoeddwyd 2010

Competing cell clones in myeloproliferative neoplasm

gan Al-Kali, Aref, Verstovsek, Srdan, Kantarjian, Hagop, Luthra, Rajyalakshmi, Cortes, Jorge
Cyhoeddwyd yn Blood (2010)

An Erythrocytosis-Associated Mutation in the Zinc Finger of PHD2 Provides Insights into Its Binding of p23

gan Song, Daisheng, Guan, Wei, Coon, Lea M, Al-Kali, Aref, Oliveira, Jennifer L, Lee, Frank S
Cyhoeddwyd yn Hypoxia (Auckl) (2019)

A nucleolin-DNMT1 regulatory axis in acute myeloid leukemogenesis

gan Shen, Na, Yan, Fei, Pang, Jiuxia, Wu, Lai-Chu, Al-Kali, Aref, Litzow, Mark R., Liu, Shujun
Cyhoeddwyd 2014

Patterns of Molecular Response to and Relapse After Combination of Sorafenib, Idarubicin, and Cytarabine in Patients With FLT3 Mutant Acute Myeloid Leukemia

gan Al-Kali, Aref, Cortes, Jorge, Faderl, Stefan, Jones, Dan, Abril, Caroline, Pierce, Sherry, Brandt, Mark, Kantarjian, Hagop, Ravandi, Farhad
Cyhoeddwyd 2011

A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome

gan Almasri, Jehad, Alkhateeb, Hassan B., Firwana, Belal, Sonbol, Mohamad Bassam, Damlaj, Moussab, Wang, Zhen, Murad, M. Hassan, Al-Kali, Aref
Cyhoeddwyd yn Syst Rev (2018)

A dynamic N(6)-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors

gan Yan, Fei, Al-Kali, Aref, Zhang, Zijie, Liu, Jun, Pang, Jiuxia, Zhao, Na, He, Chuan, Litzow, Mark R., Liu, Shujun
Cyhoeddwyd yn Cell Res (2018)

Current Event-Free Survival After Sequential Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia

gan Al-Kali, Aref, Kantarjian, Hagop, Shan, Jianqin, Bassett, Roland, Quintás-Cardama, Alfonso, Borthakur, Gautam, Jabbour, Elias, Verstovsek, Srdan, O’Brien, Susan, Cortes, Jorge
Cyhoeddwyd yn Cancer (2010)

Inactivation of receptor tyrosine kinases reverts aberrant DNA methylation in acute myeloid leukemia

gan Shen, Na, Yan, Fei, Pang, Jiuxia, Zhao, Na, Gangat, Naseema, Wu, Laichu, Bode, Ann M., Al-Kali, Aref, Litzow, Mark R., Liu, Shujun
Cyhoeddwyd yn Clin Cancer Res (2017)

Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients

gan Al-Kali, Aref, Konoplev, Sergej, Lin, Erpei, Kadia, Tapan, Faderl, Stefan, Ravandi, Farhad, Ayoubi, Mohamad, Brandt, Mark, Cortes, Jorge E., Kantarjian, Hagop, Borthakur, Gautam
Cyhoeddwyd 2012

Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis

gan Yang, Xiaojuan, Pang, Jiuxia, Shen, Na, Yan, Fei, Wu, Lai-Chu, Al-Kali, Aref, Litzow, Mark R., Peng, Yong, Lee, Robert J., Liu, Shujun
Cyhoeddwyd yn Oncotarget (2016)

Classification of Monocytes, Promonocytes and Monoblasts Using Deep Neural Network Models: An Area of Unmet Need in Diagnostic Hematopathology

gan Osman, Mazen, Akkus, Zeynettin, Jevremovic, Dragan, Nguyen, Phuong L., Roh, Dana, Al-Kali, Aref, Patnaik, Mrinal M., Nanaa, Ahmad, Rizk, Samia, Salama, Mohamed E.
Cyhoeddwyd yn J Clin Med (2021)

Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal orig...

gan Patnaik, Mrinal M., Lasho, Terra, Howard, Matthew, Finke, Christy, Ketterling, Rhett L., Al-Kali, Aref, Pardanani, Animesh, Droin, Nathalie, Gangat, Naseema, Tefferi, Ayalew, Solary, Eric
Cyhoeddwyd yn Blood Cancer J (2018)

Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS‐CoV‐2 pandemic

gan Patnaik, Mrinal M., Lasho, Terra, Padron, Eric, McCullough, Kristen, Al‐kali, Aref, Tefferi, Ayalew, Zeidan, Amer M., Gangat, Naseema, Savona, Michael, Steensma, David P., Solary, Eric
Cyhoeddwyd yn Am J Hematol (2020)

One Thousand Patients With Primary Myelofibrosis: The Mayo Clinic Experience

gan Tefferi, Ayalew, Lasho, Terra L., Jimma, Thitina, Finke, Christy M., Gangat, Naseema, Vaidya, Rakhee, Begna, Kebede H., Al-Kali, Aref, Ketterling, Rhett P., Hanson, Curtis A., Pardanani, Animesh
Cyhoeddwyd 2012

The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia

gan Tibes, Raoul, Al-Kali, Aref, Oliver, Gavin R, Delman, Devora H, Hansen, Nanna, Bhagavatula, Keerthi, Mohan, Jayaram, Rakhshan, Fariborz, Wood, Thomas, Foran, James M., Mesa, Ruben A., Bogenberger, James M.
Cyhoeddwyd yn J Hematol Oncol (2015)

Histone deacetylase inhibitors reduce differentiating osteoblast-mediated protection of acute myeloid leukemia cells from cytarabine

gan Sterner, Rosalie M., Kremer, Kimberly N., Al-Kali, Aref, Patnaik, Mrinal M., Gangat, Naseema, Litzow, Mark R., Kaufmann, Scott H., Westendorf, Jennifer J., van Wijnen, Andre J., Hedin, Karen E.
Cyhoeddwyd yn Oncotarget (2017)

Momelotinib therapy for myelofibrosis: a 7-year follow-up

gan Tefferi, Ayalew, Barraco, Daniela, Lasho, Terra L., Shah, Sahrish, Begna, Kebede H., Al-Kali, Aref, Hogan, William J., Litzow, Mark R., Hanson, Curtis A., Ketterling, Rhett P., Gangat, Naseema, Pardanani, Animesh
Cyhoeddwyd yn Blood Cancer J (2018)